Free Trial
OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

$2.09 +0.19 (+10.00%)
As of 07/16/2025

About EKIMAS Stock (OTCMKTS:ASNB)

Key Stats

Today's Range
$2.00
$2.09
50-Day Range
$1.90
$5.00
52-Week Range
$0.55
$1.75
Volume
440 shs
Average Volume
3,162 shs
Market Capitalization
$12.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

ASNB Stock News Headlines

EKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTS
I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
Updated EKIMAS Corporation Announces Special Cash Distribution
What does ‘WYLL’ mean on TikTok and Snapchat?
EKIMAS Corporation (ASNB)
See More Headlines

ASNB Stock Analysis - Frequently Asked Questions

EKIMAS's stock was trading at $9.00 at the start of the year. Since then, ASNB shares have decreased by 76.8% and is now trading at $2.09.

EKIMAS Co. (OTCMKTS:ASNB) issued its earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02.

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that EKIMAS investors own include Associated Banc (ASB), MediWound (MDWD), PermRock Royalty Trust (PRT), Meta Platforms (META), Adobe (ADBE), Actinium Pharmaceuticals (ATNM) and CytoDyn (CYDY).

Company Calendar

Last Earnings
10/16/2014
Today
7/18/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Business Services
Current Symbol
OTCMKTS:ASNB
Previous Symbol
AMEX:ASB
CIK
1011060
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-7,902.31%
Return on Assets
-5,274.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.12
Quick Ratio
0.12

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
69.67

Miscellaneous

Outstanding Shares
5,799,000
Free Float
5,347,000
Market Cap
$12.12 million
Optionable
Not Optionable
Beta
0.37
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:ASNB) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners